Norges Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Norges Bank’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,600	Closed	-$270K	–	2167
2021 Q4	$270K	Sell	11,600 -80,600	-87%	-$1.65M	﹤0.01%	2180
2021 Q3	$1.75M	Buy	92,200 +27,700	+43%	+$543K	﹤0.01%	2073
2021 Q2	$1.3M	Buy	+64,500	New	+$1.22M	﹤0.01%	2075
2019 Q4	–	Sell	-25,000	Closed	-$496K	–	2077
2019 Q3	$496K	Buy	+25,000	New	+$521K	﹤0.01%	2061
2015 Q1	–	Sell	-17,968	Closed	-$209K	–	2284
2014 Q4	$209K	Sell	17,968 -95,000	-84%	-$1.03M	﹤0.01%	2295
2014 Q3	$1.32M	Buy	+112,968	New	+$1.18M	﹤0.01%	2165

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank's AMPH Position: Q1 2022 in Review

Norges Bank sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 11,600 shares — an estimated $270K sold.

Norges Bank first reported a position in AMPH in Q3 2014 and held it in 6 quarters. The position peaked at $1.75M in Q3 2021. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

Norges Bank reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Norges Bank sold 11,600 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $270K.
Norges Bank first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 6 quarters.
Norges Bank's Amphastar Pharmaceuticals position peaked at $1.75M in Q3 2021.
203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Norges Bank's 13F filing for Q1 2022, filed 9 May 2022.